Novavax AB Email Format
Pharmaceutical ManufacturingUppsala, Sweden201-500 Employees
Novavax AB operates as a fully owned subsidiary of Novavax Inc., within the pharmaceutical manufacturing sector. The company focuses on the discovery, development, and commercialization of vaccines aimed at preventing serious infectious diseases, leveraging recombinant nanoparticle technology and an adjuvant approach to support safe and effective immunization. Its product pipeline includes candidates in clinical development for respiratory syncytial virus, seasonal and pandemic influenza, and Ebola, with additional programs at the preclinical stage.